BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zewail MB, F Asaad G, Swellam SM, Abd-Allah SM, K Hosny S, Sallah SK, E Eissa J, S Mohamed S, El-Dakroury WA. Design, characterization and in vivo performance of solid lipid nanoparticles (SLNs)-loaded mucoadhesive buccal tablets for efficient delivery of Lornoxicam in experimental inflammation. Int J Pharm 2022;624:122006. [PMID: 35820515 DOI: 10.1016/j.ijpharm.2022.122006] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 El-Mahdy HA, Elsakka EGE, El-Husseiny AA, Ismail A, Yehia AM, Abdelmaksoud NM, Elshimy RAA, Noshy M, Doghish AS. miRNAs role in bladder cancer pathogenesis and targeted therapy: Signaling pathways interplay - A review. Pathol Res Pract 2023;242:154316. [PMID: 36682282 DOI: 10.1016/j.prp.2023.154316] [Reference Citation Analysis]
2 Nomier YA, Alshahrani S, Elsabahy M, Asaad GF, Hassan A, El-dakroury WA. Ameliorative effect of chitosan nanoparticles against carbon tetrachloride-induced nephrotoxicity in Wistar rats. Pharmaceutical Biology 2022;60:2134-2144. [DOI: 10.1080/13880209.2022.2136208] [Reference Citation Analysis]
3 Kumar R, Thakur AK, Kulabhi A, Mishra A. Solubility Prediction of Lornoxicam in Different Pure Solvents Using Semi-Empirical Correlations and Thermodynamic Models. International Journal of Thermodynamics 2022. [DOI: 10.5541/ijot.1138056] [Reference Citation Analysis]
4 El-dakroury WA, Zewail MB, Amin MM. Design, optimization, and in-vivo performance of glipizide-loaded O-carboxymethyl chitosan nanoparticles in insulin resistant/type 2 diabetic rat model. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.104040] [Reference Citation Analysis]